Literature DB >> 21484581

[Muscle channelopathies. Myotonias and periodic paralyses].

K Jurkat-Rott1, H Lerche, F Lehmann-Horn.   

Abstract

The myotonias and familial periodic paralyses are muscle channelopathies. They have in common an impaired muscle excitation that is caused by mutations in voltage-gated Na(+), K(+), Ca(2+), and Cl(-) channels. Membrane hyperexcitability usually results in myotonic stiffness; with increasing membrane depolarization hyperexcitability can be transiently turned into hypoexcitability causing transient weakness as in severe myotonia. Hypoexcitability due to long-lasting depolarization that inhibits action potential generation is the common mechanism for the periodic paralyses. Interictally, the ion channel malfunction may be compensated, so that specific exogenous or endogenous provocative factors are required to produce symptoms in the patients. An especially obvious triggering agent is the level of serum potassium, the ion decisive for resting membrane potential and degree of excitability. Periodic paralysis mutations for which the ion channel malfunction is not fully compensated interictally cause progressive myopathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21484581     DOI: 10.1007/s00115-011-3269-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  19 in total

1.  Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis.

Authors:  R Tawil; M P McDermott; R Brown; B C Shapiro; L J Ptacek; P G McManis; M C Dalakas; S A Spector; J R Mendell; A F Hahn; R C Griggs
Journal:  Ann Neurol       Date:  2000-01       Impact factor: 10.422

Review 2.  Complications of anaesthesia in neuromuscular disorders.

Authors:  Werner Klingler; Frank Lehmann-Horn; Karin Jurkat-Rott
Journal:  Neuromuscul Disord       Date:  2005-01-28       Impact factor: 4.296

Review 3.  Voltage-gated ion channels and hereditary disease.

Authors:  F Lehmann-Horn; K Jurkat-Rott
Journal:  Physiol Rev       Date:  1999-10       Impact factor: 37.312

4.  Transient weakness and compound muscle action potential decrement in myotonia congenita.

Authors:  F Deymeer; S Cakirkaya; P Serdaroğlu; L Schleithoff; F Lehmann-Horn; R Rüdel; C Ozdemir
Journal:  Muscle Nerve       Date:  1998-10       Impact factor: 3.217

Review 5.  Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

6.  Clinical, electrophysiologic, and genetic study of non-dystrophic myotonia in French-Canadians.

Authors:  Nicolas Dupré; Nicolas Chrestian; Jean-Pierre Bouchard; Elsa Rossignol; Denis Brunet; Damien Sternberg; Bernard Brais; Jean Mathieu; Jack Puymirat
Journal:  Neuromuscul Disord       Date:  2008-03-11       Impact factor: 4.296

7.  K+-dependent paradoxical membrane depolarization and Na+ overload, major and reversible contributors to weakness by ion channel leaks.

Authors:  Karin Jurkat-Rott; Marc-André Weber; Michael Fauler; Xiu-Hai Guo; Boris D Holzherr; Agathe Paczulla; Nikolai Nordsborg; Wolfgang Joechle; Frank Lehmann-Horn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

8.  Myotonia fluctuans. A third type of muscle sodium channel disease.

Authors:  K Ricker; R T Moxley; R Heine; F Lehmann-Horn
Journal:  Arch Neurol       Date:  1994-11

9.  Progressive muscle atrophy with hypokalemic periodic paralysis and calcium channel mutation.

Authors:  Thomas Meyer; Karin Jurkat-Rott; Angela Huebner; Frank Lehmann-Horn; Peter Linke; Frank Van Landeghem; Jörn S Dullinger; Simone Spuler
Journal:  Muscle Nerve       Date:  2008-01       Impact factor: 3.217

Review 10.  Treatment for periodic paralysis.

Authors:  V Sansone; G Meola; T P Links; M Panzeri; M R Rose
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.